Shannon Ewing, MD
Dermatology · Skokie, ILNPI 1598845695
Payments from drug & device makers
What this record shows
Novartis accounts for 87.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,042, more than ten times the $13 reported in 2022. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.
Across 12 payments — averaging $105.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$49
- E.r. Squibb & Sons, L.L.C.$48
- Amgen$39
- Incyte Corporation$26
Across 19 payments — averaging $11,095 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$154K
- Eli Lilly$34K
- Incyte Corporation$21K
- AbbVie$1K
What the payments were for
- Travel & lodging$68954%
- Food & beverage$58146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $1,108 |
| AbbVie | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 1 | $48 |
| Amgen | 3 | $39 |
| Incyte Corporation | 1 | $26 |
How this compares
$1,270 in reported general payments places this provider in the 40th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 87 | $5,988 |
| Tacrolimus | 50 | $4,932 |
| Clobetasol Propionate | 65 | $2,972 |
| CiclopiroxCiclopirox Olamine | 90 | $2,368 |
| Pimecrolimus | 11 | $1,807 |
| Doxycycline Hyclate | 67 | $1,662 |
| Fluorouracil | 24 | $1,644 |
| ValacyclovirValacyclovir Hcl | 47 | $1,364 |
| Minoxidil | 82 | $1,246 |
| Clindamycin Phosphate | 18 | $1,088 |
| Fluocinonide | 35 | $1,062 |
| Triamcinolone Acetonide | 130 | $967 |
| Betamethasone Dipropionate | 17 | $720 |
| Ketoconazole | 40 | $552 |
| Ciclopirox | 14 | $448 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Skokie
- Stephanie MehlisSkokie$145K
- Benjamin GardenSkokie$22K
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.